Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Cube will underpin many of the AI tools we will develop in the years to come, including highly complex scene-generation tools ...
Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug ...
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares shot up 2.1% during trading on Wednesday after Bank of America raised their price target on the stock from $21.00 to $22.00. Bank of ...
The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...
AlphaQuest LLC cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 11.2% during the 4th ...
Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...
We recently published a list of 15 Stocks That Outperform the S&P 500 Every Year For the Last 3 Years. In this article, we ...
We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where Hims & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results